DexCom DXCM Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.19B+15.0% | $1.26B+13.1% | $1.21B+21.6% | $1.16B+15.2% | $1.04B+12.5% | ||
| $441.6M-1.2% | $466.9M+2.0% | $477.9M+19.4% | $468.3M+24.0% | $447M+24.5% | ||
| $750.3M+27.4% | $792.7M+20.9% | $731.4M+23.2% | $688.8M+9.9% | $589M+4.8% | ||
| 62.9%+6.1pp | 62.9%+4.0pp | 60.5%+0.8pp | 59.5%-2.9pp | 56.9%-4.2pp | ||
| $145.3M+0.1% | $148.2M+6.2% | $157.5M+16.3% | $148.2M+9.0% | $145.2M+2.6% | ||
| $349.7M+12.8% | $321.5M-1.8% | $331.4M+8.2% | $328M-1.4% | $310.1M-2.9% | ||
| $67.1M+11.8% | $65.2M+12.8% | $63.6M+15.0% | $63M+20.9% | $60M+14.3% | ||
| $495M+8.7% | $469.7M+0.6% | $488.9M+10.7% | $476.2M+1.6% | $455.3M-1.2% | ||
| $495M+8.7% | $469.7M+0.6% | $488.9M+10.7% | $476.2M+1.6% | $455.3M-1.2% | ||
| $255.3M+90.9% | $323M+71.0% | $242.5M+59.5% | $212.6M+34.6% | $133.7M+32.2% | ||
| 21.4%+8.5pp | 25.6%+8.7pp | 20.1%+4.8pp | 18.4%+2.6pp | 12.9%+1.9pp | ||
| $14.2M-31.1% | $17.7M-21.0% | $109.8M+332% | $28.5M-4.4% | $20.6M-34.4% | ||
| $269.5M+74.7% | $340.7M+61.2% | $352.3M+98.6% | $241.1M+28.4% | $154.3M+16.5% | ||
| $70M+43.1% | $73.4M+23.2% | $68.5M+60.0% | $61.3M+38.4% | $48.9M+452% | ||
| $199.5M+89.3% | $267.3M+76.2% | $283.8M+111% | $179.8M+25.3% | $105.4M-28.0% | ||
| 16.7%+6.6pp | 21.2%+7.6pp | 23.5%+9.9pp | 15.5%+1.3pp | 10.2%-5.7pp | ||
| $0.51+88.9% | $0.67+76.3% | $0.70+106% | $0.45+28.6% | $0.27-25.0% | ||
| $0.52+92.6% | $0.69+81.6% | $0.73+115% | $0.46+27.8% | $0.27-28.9% | ||
| 393.6M-3.4% | 405.5M-1.7% | 407.4M-0.7% | 408.2M-2.1% | 407.5M-2.2% | ||
| 385.1M-1.5% | 390.2M-0.9% | 391.1M-0.8% | 392.1M-1.8% | 391.1M+0.2% | ||
| $14.2M-31.1% | $17.7M-21.0% | $109.8M+332% | $28.5M-4.4% | $20.6M-34.4% | ||
| $1.19B+15.0% | $1.26B+13.1% | $1.21B+21.6% | $1.16B+15.2% | $1.04B+12.5% | ||
| $322.4M+66.4% | $388.2M+57.4% | $306.1M+47.7% | $275.6M+31.2% | $193.7M+26.1% | ||
| 27%+8.4pp | 30.8%+8.7pp | 25.3%+4.5pp | 23.8%+2.9pp | 18.7%+2.0pp | ||
| $255.3M+90.9% | $323M+71.0% | $242.5M+59.5% | $212.6M+34.6% | $133.7M+32.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is DexCom's revenue?
- DexCom (DXCM) generated $4.8B in revenue over the trailing twelve months, up 16.2% year over year.
- Is DexCom profitable?
- DexCom reported $930.4M in net income over the trailing twelve months, a 19.3% net margin.
- What are DexCom's profit margins?
- Gross margin is 61.5% and operating margin is 21.4%, with a 19.3% net margin.
- What is DexCom's earnings per share?
- DexCom's diluted EPS over the trailing twelve months is $2.33.
- Where does DexCom's income statement data come from?
- Every line is extracted from DexCom's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
